This is another fantastic article from the ASCO Conference
I love the fact they provide abstracts of the notes for patients and other interested people like us (Thank-You!).
This is a great evaluation of 126 cases of Metaplastic Breast Cancer (MBC) and gene mutations.
I love this quote from the abstract: "The low RRM1 expression rate suggests possible gemcitabine effectiveness".